Who We Are: EMD Serono is the North American biopharma brand of Merck KGaA, Darmstadt, Germany - a leading science and technology company - focused exclusively on specialty care. For more than 40 years, the brand has integrated cutting-edge science, innovative products and industry-leading patient support and access programs. EMD Serono has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in oncology, immuno-oncology and immunology as R&D focus areas.
Our Bioinformatics group supports the Immunology and Immuno-Oncology departments from target discovery through clinical biomarker analysis. We’re part of Global Early Development, a multi-disciplinary department that also includes Clinical Pharmacology, Clinical Biomarkers and Companion Diagnostics, Drug Disposition, and Modeling & Simulation. You will have the opportunity to expand their drug development skills by collaborating with and learning from experts across all of these areas.
Who You Are: In our team, you will focus on target discovery through network biology and integration of high-throughput datasets, both genomic and phenotypic. You’ll also lead the Bioinformatics contribution to external industry and academic collaborations, ensuring that EMD Serono is a valued scientific partner and that we maximize the utility to our programs.
We’re looking for candidates with a strong background designing and applying computational methods to solve problems in high-throughput biology and drug discovery, in either academic or industry settings. You must have successfully worked in collaborations that span research groups and institutions. You should have experience in all aspects of computational projects- data management and processing pipelines, algorithms, interpretation with biologists, and presentation/publication.
Our ideal new team member will have
- a PhD in a relevant field (computational biology, bioinformatics, computer science, bioengineering) and 5-8 years experience (industry or post-PhD academic)
- demonstrated expertise in biological network construction and analysis as well as the integration of multiple datatypes
- experience with a variety of computational biology techniques, software packages, and algorithms, especially for large ‘omics datasets (genomics, expression data, proteomics, phenotypic screens, and perhaps metabolomics)
- strong programming (eg, R, python), database, and software engineering skills for building computational infrastructure rather than a series of one-off analyses
- experience with numerous databases (eg, SRA, GEO, MsigDB, MetaBase) and datasets (eg, TCGA, GTEx, ImmGen)
- successfully managed, or participated in as a key member, several collaborative efforts involving complex analyses
- a strong publication record illustrating their above experiences
What we offer: Your possibilities to develop in our growing company are just as manifold as our product portfolio. We offer a modern and international working environment to unleash your innovative potential in diverse teams, and take responsibility for our employees, products, the environment and society.
EMD Serono is an Equal Employment Opportunity employer. No employee or applicant for employment will be discriminated against on the basis of race, color, religion, age, sex, sexual orientation, national origin, ancestry, disability, military or veteran status, genetic information, gender identity, transgender status, marital status, or any other classification protected by applicable federal, state, or local law. This policy of Equal Employment Opportunity applies to all policies and programs relating to recruitment and hiring, promotion, compensation, benefits, discipline, termination, and all other terms and conditions of employment. Any applicant or employee who believes they have been discriminated against by the Company or anyone acting on behalf of the Company must report any concerns to his/her Human Resources Business Partner, Legal, or Compliance immediately. The Company will not retaliate against any individual because he/she made a good faith report of discrimination.